Use of a dipeptide for stimulating repair processes
CA 2335362 C · Owner: Morozov, Vyacheslav Grigorievich · Inventors: Sery, Sergei Vladimirovich; Malinin, Vladimir Viktorovich; Khavinson, Vladimir Khatskelevich
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
L-Lys-L-GIu dipeptide is proposed for use in medicine for preparation of a drug capable of , stimulating processes. According to the invention the pharmaceutical peptide , preparation capable of stimulating regeneration consists of pharmaceutically admissible carrier and effective, quantity of dipeptides as an active part which is a combination of. L-lysil-L-, gluthmine acid or its salts. The pharmaceutical peptide preparation is proposed for the parental, intranasal, oral and , local application. According to the invention the method stimulating , regeneration consists of prophylactic and/or treatment injections of the drug in the dose of 0,0.1-100 µg per kg of , weight, at least …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 27, 1999 and granted November 20, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 27, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.